Molecular Templates Inc. (NASDAQ: MTEM)
$1.40
-0.0100 ( -0.71% ) 45.2K
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
Market Data
Open
$1.40
Previous close
$1.41
Volume
45.2K
Market cap
$9.15M
Day range
$1.23 - $1.43
52 week range
$1.01 - $9.45
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jun 03, 2024 |
| 8-k | 8K-related | 15 | May 15, 2024 |
| 10-q | Quarterly Reports | 80 | May 15, 2024 |
| 10-k/a | Quarterly Reports | 17 | Apr 25, 2024 |
| 8-k | 8K-related | 13 | Apr 12, 2024 |
| 4 | Insider transactions | 1 | Apr 04, 2024 |
| 4 | Insider transactions | 1 | Apr 04, 2024 |
| 10-k | Annual reports | 103 | Mar 29, 2024 |
| 8-k | 8K-related | 15 | Mar 29, 2024 |
| 8-k | 8K-related | 17 | Mar 28, 2024 |